About
Nova Biomedical is a leading developer and manufacturer of advanced medical devices and diagnostic equipment, focusing on fast, whole blood analyzers for hospitalized and critically ill patients. Founded in 1976, the company employs over 1,200 people globally, including a dedicated team of scientists and engineers. With facilities in Massachusetts and Taipei, Nova Biomedical is recognized as the largest privately held in vitro diagnostic company in the U.S. and ranks among the top 25 globally. The company offers a diverse range of products, including blood gas and critical care analyzers known for their speed and accuracy, glucose monitoring systems marketed under the Nova Max® brand, and innovative instruments for real-time cell culture monitoring in biomanufacturing. Nova Biomedical also provides high-performance analyzers for veterinary diagnostics and serves as a partner for contract development and manufacturing. With a strong commitment to research and development, Nova Biomedical continues to deliver reliable and high-quality diagnostic solutions to customers in over 100 countries.
Technologies
Keywords
Company Information
-
Employees 1400
-
Founded 1976
-
Annual Revenue $360900000
Location
200 Prospect Street, Waltham, Massachusetts, United States, 02453
